Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 13.05
+0.04 (0.31%)
At close: Apr 30, 2025, 2:57 PM CST
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 5.19 billion as of May 2, 2025. Its market cap has decreased by -28.02% in one year.
Market Cap
5.19B
Enterprise Value
4.05B
Revenue
1.78B
Ranking
n/a
PE Ratio
178.09
Stock Price
13.05
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 5.19B, a decrease of -69.05%. That is a compound annual growth rate of -42.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 5.19B | -3.55% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.92B |
| Shenzhen Mindray Bio-Medical Electronics | 265.66B |
| WuXi AppTec | 168.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.88B |
| Aier Eye Hospital Group | 120.68B |
| Sichuan Biokin Pharmaceutical | 114.72B |
| Shanghai United Imaging Healthcare | 108.98B |
| Yunnan Baiyao Group Co.,Ltd | 102.18B |